Latest Recruitments & Recent News

Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group

Successful Placement at Avidity

The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader

The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics

The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals

The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics

The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals

Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics

Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group

The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology

The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics

Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit

Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team

Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership With The Chase Group, Inc.

Ionis Pharmaceuticals Secures Associate Director, Investor Relations

A Successful Placement at Eisai, Inc.

The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals

Vice President of Drug Safety for Ionis Pharmaceuticals Secured

Ionis Engages The Chase Group to Continue Building QA Team

Atsena Therapeutics Process Development Opportunity

Arcturus Retains The Chase Group to Expand Vaccine Development Programs

The Chase Group Secures SVP, Regulatory for Atsena Therapeutics in Impressive Timeframe

The Chase Group Retained to Identify Vice President, Manufacturing/Supply Chain

Successful Collaboration Results in VP Finance Placement at Ionis

Alexza Pharmaceuticals Partnership Continues with Quality Assurance Leadership Search

Atsena Therapeutics Retains The Chase Group to Identify Head of Regulatory

Ventria Continues Partnership With The Chase Group to Find Agronomy Operations Leader

Ventria Bioscience Cuts to The Chase!

Ferrer Partners With The Chase Group to Identify US Business Development Leader

The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals

The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics

Alexza Pharmaceuticals Continues Partnership With The Chase Group to Seek Clinical Operations Leader

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics

Head of Drug Safety Search Expands Partnership of Arcturus Therapeutics and The Chase Group

Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership With The Chase Group

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs, for Akcea Therapeutics

Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group

The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics

Akcea Therapeutics Turns to The Chase Group to Secure Chief Medical Officer

Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit

Akcea Therapeutics Retains The Chase Group to Secure Senior Vice President for Global Medical Affairs

A New Decade, A New Partnership, and Continued Growth for Alexza Pharmaceuticals and The Chase Group

Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team

Eisai, Inc. Retains The Chase Group to Build US Medical Affairs Leadership Team

Akcea Retains The Chase Group to Secure Senior HR Leader for the Company’s Executive Team

The Chase Group Drug Safety Expertise Utilized by Ionis Pharmaceuticals

Eisai, Inc. Cuts to the Chase for Their Recruiting Expertise in Global Medical Affairs, Oncology

Through Partnership With The Chase Group, Aeglea BioTherapeutics Continues Building Rare Disease Clinical Development Leadership Team

Aeglea BioTherapeutics (NASDAQ: AGLE) Partners with The Chase Group to Build Clinical Development Team for Rapidly Expanding Genetic Rare Disease Portfolio

Ionis Pharmaceuticals Secures Associate Director, Investor Relations

A Successful Placement at Eisai, Inc.

Ionis Pharmaceuticals Continues to Cut to the Chase

Ipsen US Retains The Chase Group to Recruit a Vice President, Neurology Franchise Head

The Momentum Continues at Ionis Pharmaceuticals

The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals

Client Promotion Results in New GCP QA Talent Search

Eisai Retains The Chase Group to Find a Medical Director, Subject Matter Expert in Epilepsy

The Chase Group Recruits Newly Created Vice President of Finance Role for Ionis Pharmaceuticals

Ipsen Taps The Chase Group for Sr. Business Analytics Search

Ipsen NA Cuts to the Chase Once Again!

Vice President of Finance Search

Corporate Communications Executive Secured for Ipsen Biopharmaceuticals

IPSEN US Retains The Chase Group to Fill Executive Level Communications Leadership Role

Eli Lilly Engages The Chase Group to Find GI Medical Oncologist

VP of Marketing Search Closes

Five Placements Completed in Record Time for Ipsen Biopharmaceuticals

Ipsen Retains The Chase Group for Senior Marketers

CNS Medical Affairs Search Begins

AbbVie Global Regulatory Affairs and The Chase Group Partner Once Again!